Physician profile
James R Kirkpatrick
NPI 1225471915
$870.66
in general payments reported to CMS, 2019-2025
19 companies · $22.07 in 2025
The $22.07 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $28.95 · 2021: $17.73 · 2022: $174 · 2023: $395 · 2024: $80.53 · 2025: $22.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $245.58 | 2020-2024 | Breztri, Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $87.90 | 2022-2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Novo Nordisk INC | $85.91 | 2022-2024 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $78.03 | 2019-2023 | Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $62.82 | 2023-2024 | Gemtesa |
| Lilly USA, LLC | $44.08 | 2019-2022 | |
| Dexcom, INC. | $37.17 | 2021-2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $30.87 | 2019 | |
| Amarin Pharma, INC. | $29.84 | 2019 | |
| Lundbeck LLC | $24.93 | 2024 | Vyepti |
| Exact Sciences Corporation | $22.07 | 2025 | The Cologuard Plus Collection Kit |
| Optinose US, INC. | $19.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.55 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.34 | 2023 | Jardiance, Tradjenta |
| Sanofi Pasteur INC. | $14.95 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.66 | 2023 | Xifaxan |
| Si-Bone, INC. | $13.23 | 2020 | |
| Amgen INC. | $13.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kirkpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.